Keyword: multiple sclerosis treatment
News
12.08.2014
- US generic drugmaker Mylan has shaved the top end of its full-year revenue and earnings forecasts slightly, citing delays in approval from the US Food and Drug Administration for...
News
25.07.2014
- Merck Serono, the biopharmaceuticals arm of Germany's Merck KgaA, is extending by two years its 10-year R&D cooperation with San Raffaele University & Research Hospital for...
News
27.11.2013
- German chemicals and pharmaceutical group Merck KGaA has added two new partners, the newly created Metabomed and the start-up ChanBio, to its €10 million Merck Serono Israel...
News
07.10.2013
- Biogen Idec's hot-selling new multiple sclerosis drug Tecfidera remained effective for patients taking the medicine for at least four years with no new safety problems, according...
News
10.09.2013
- Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals as part of a broad collaboration to develop new medicines for neurological disorders, the...
News
18.07.2013
- Novartis raised its full-year outlook on Wednesday after generic competition to its best-selling blood pressure pill was delayed, granting the Swiss drugmaker a temporary reprieve...
